The Innovative Medicines Initiative (IMI) has launched a new project called GETREAL that will investigate new ways of integrating data from real life settings, such as clinics, into drug development. This will assist healthcare decision makers when deciding how best to grant patients access to a new treatment and help pharmaceutical companies to take better decisions during drug development.Once a new drug has been developed, it must be reviewed by both the marketing authorisation and health technology assessment (HTA) bodies.
More...
More...